Skip to main content
The British Journal of Cancer. Supplement logoLink to The British Journal of Cancer. Supplement
. 1980 Apr;4:279–287.

Experimental chemotherapy studies: intercomparison of assays.

P R Twentyman
PMCID: PMC2149247  PMID: 7000124

Abstract

In a limited number of experimental tumour systems the response to chemotherapy has been measured in terms of both cell survival and tumour growth delay. Both of these endpoints have complicating factors which lead to problems in interpretation of results. The time after drug administration at which cell survival is measured can be of predominant importance. If the time is too short, drug action may be incomplete and recovery from potentially lethal damage may still be occurring. If the time is too long, proliferation of surviving clonogenic cells may have begun. Tumour growth delay on the other hand is likely to be influenced by the effect of the chemotherapy on the host, as well as on the tumour. This may be particularly important when the tumour is significantly immunogenic. The rate of regenerative proliferation of the surviving clonogenic cells can be different following treatment with different cytotoxic drugs, hence resulting in different periods of growth delay from the same initial level of cell killing. Also some agents appear to be significantly cytostatic, producing considerable growth delay in the absence of cell killing. New data are also presented for the RIF-1 tumour and for multicellular tumour spheroids of the EMT6/Ca/VJAC line.

Full text

PDF
282

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Begg A. C., Fu K. K., Kane L. J., Phillips T. L. Single-agent chemotherapy of a solid murine tumor assayed by growth delay and cell survival. Cancer Res. 1980 Jan;40(1):145–154. [PubMed] [Google Scholar]
  2. Brown J. M. Drug or radiation changes to the host which could affect the outcome of combined modality therapy. Int J Radiat Oncol Biol Phys. 1979 Aug;5(8):1151–1163. doi: 10.1016/0360-3016(79)90635-7. [DOI] [PubMed] [Google Scholar]
  3. Dethlefsen L. A., Riley R. M., Roti Roti J. L. Flow cytometric analysis of adriamycin-perturbed mouse mammary tumors. J Histochem Cytochem. 1979 Jan;27(1):463–469. doi: 10.1177/27.1.374611. [DOI] [PubMed] [Google Scholar]
  4. Hermens A. F., Barendsen G. W. Changes of cell proliferation characteristics in a rat rhabdomyosarcoma before and after x-irradiation. Eur J Cancer. 1969 May;5(2):173–189. doi: 10.1016/0014-2964(69)90065-6. [DOI] [PubMed] [Google Scholar]
  5. Moore J. V., Dixon B. The gross and cellular response of a rat mammary tumour to single doses of cyclophosphamide. Eur J Cancer. 1978 Jan;14(1):91–95. doi: 10.1016/0014-2964(78)90142-1. [DOI] [PubMed] [Google Scholar]
  6. Steel G. G., Adams K. Stem-cell survival and tumor control in the Lewis lung carcinoma. Cancer Res. 1975 Jun;35(6):1530–1535. [PubMed] [Google Scholar]
  7. Stephens T. C., Currie G. A., Peacock J. H. Repopulation of gamma-irradiated Lewis lung carcinoma by malignant cells and host macrophage progenitors. Br J Cancer. 1978 Nov;38(5):573–582. doi: 10.1038/bjc.1978.252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Stephens T. C., Peacock J. H. Cell yield and cell survival following chemotherapy of the B16 melanoma. Br J Cancer. 1978 Nov;38(5):591–598. doi: 10.1038/bjc.1978.254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Stephens T. C., Peacock J. H. Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea. Br J Cancer. 1977 Sep;36(3):313–321. doi: 10.1038/bjc.1977.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Twentyman P. R. An artefact in clonogenic assays of bleomycin cytotoxicity. Br J Cancer. 1977 Nov;36(5):642–644. doi: 10.1038/bjc.1977.243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Twentyman P. R. Sensitivity to 1,3-bis(2-chloroethyl)-1-nitrosourea and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea of the EMT6 tumor in vivo as determined by both tumor volume response and in vitro plating assay. Cancer Res. 1978 Aug;38(8):2395–2400. [PubMed] [Google Scholar]
  12. Twentyman P. R. Sensitivity to cytotoxic agents of the EMT6 tumour in vivo: tumour volume versus in vitro plating. 1. Cyclophosphamide. Br J Cancer. 1977 Feb;35(2):208–217. doi: 10.1038/bjc.1977.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Twentyman P. R. Timing of assays: an important consideration in the determination of clonogenic cell survival both in vitro and in vivo. Int J Radiat Oncol Biol Phys. 1979 Aug;5(8):1213–1220. doi: 10.1016/0360-3016(79)90641-2. [DOI] [PubMed] [Google Scholar]
  14. Yuhas J. M., Li A. P., Martinez A. O., Ladman A. J. A simplified method for production and growth of multicellular tumor spheroids. Cancer Res. 1977 Oct;37(10):3639–3643. [PubMed] [Google Scholar]

Articles from The British Journal of Cancer. Supplement are provided here courtesy of Cancer Research UK

RESOURCES